A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading. The British drugmaker’s Avodart capsules treat symptoms of enlarged prostate, including frequent…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook

Read more:
FDA calls Glaxo ad for prostate drug ‘misleading’